Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Purpose: To evaluate the role of adjuvent micropulse laser with Aflibercept injections in the
management of treatment naïve centre involving DME, looking at decreased treatment burden and
increased efficacy as outcomes.
Methods: This was a prospective, single centre, randomized trial that included 40 eyes (40
patients) with previously untreated centre involved DME. Patients were randomly assigned to
receive either Aflibercept plus micropulse laser (group A) or Aflibercept monotherapy (group
B).